Co-Diagnostics, Inc. to Present at MarketsandMarkets Conference on March 23-24 in London, EnglandPRNewsWire • 03/22/22
CoDiagnostics, Inc. (CODX) Surges 13.1%: Is This an Indication of Further Gains?Zacks Investment Research • 03/16/22
Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase ProgramPRNewsWire • 03/15/22
CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND WEBCASTPRNewsWire • 03/14/22
Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State CapitalPRNewsWire • 02/10/22
Co-Diagnostics says its joint venture CoSara receives clearance from Indian regulators from Hepatitis B viral load testProactive Investors • 02/03/22
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load TestPRNewsWire • 02/03/22
Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2022 in Dubai on January 24-27PRNewsWire • 01/21/22
Co-Diagnostics says CoSara JV wins Indian regulatory clearance to sell its SARAGENE Human Papillomavirus High-Risk Real-Time PCR testProactive Investors • 01/13/22
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex TestPRNewsWire • 01/13/22
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13PRNewsWire • 01/10/22
Has CoDiagnostics, Inc. (CODX) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 01/05/22
Co-Diagnostics completes acquisition of Idaho Molecular and Advanced Conception to expand its at-home/point-of-care diagnostic deviceProactive Investors • 12/31/21
Co-Diagnostics, Inc. Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care PlatformPRNewsWire • 12/31/21
Co-Diagnostics fighting coronavirus (COVID-19) with flagship test, plans at-home PCR-based platformProactive Investors • 12/22/21